Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0QF2W
|
||||
Former ID |
DIB002390
|
||||
Drug Name |
AGTC-0106
|
||||
Synonyms |
Alpha-1 antitrypsin deficiency gene therapy, AGTC; RAAV1-CB-hAAT; Gene therapy (alpha-1 antitrypsin deficiency), Applied Genetic Technologies
|
||||
Indication | Alpha-1 antitrypsin deficiency [ICD9: 273.4; ICD10:E88.0] | Phase 2 | [522924] | ||
Company |
Agtc; applied genetic technologies
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1-antitrypsin | Target Info | Modulator | [525389] | |
KEGG Pathway | Complement and coagulation cascades | ||||
NetPath Pathway | IL6 Signaling Pathway | ||||
PANTHER Pathway | Blood coagulation | ||||
Pathway Interaction Database | p73 transcription factor network | ||||
FOXA1 transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.